M.HagedornT
Tirzepatide-based mediations like Zepbound and Wegovy have been shown to have better weight loss indications, as they create the sense of fullness that Semaglutide GLP-1 is known for, but help reduce food cravings in patients which can stop over-eating that some patients on Ssemaglutide GLP-1 report doing
Dermatology 15, 514519
Not actual vial For marketing purposes only GLP-1 Core semaglutide Starting at (All doses) Targets the GLP-1 receptor to help regulate appetite, slow gastric emptying, and support healthy glucose levels Ideal for first-time metabolic patients or those with moderate weight-loss goals 4 Weeks of Medication Ongoing Provider Care & Support Metabolic Lab Testing Every 6 Months GLP-1 Core semaglutide Starting at (All doses) Targets the GLP-1 receptor to help regulate appetite, slow gastric emptying, and support healthy glucose levels Ideal for first-time metabolic patients or those with moderate weight-loss goals 4 Weeks of Medication Ongoing Provider Care & Support Metabolic Lab Testing Every 6 Months Not actual vial For marketing purposes only GLP-1 Advanced tirzepatide Starting at (All Doses) Adds GIP receptor activation for broader insulin and satiety signalinghelpful when GLP-1 alone plateaus Ideal for patients needing extra glucose control or stronger appetite modulation for greater weight-loss goals 4 Weeks of Medication Ongoing Provider Care & Support Metabolic Lab Testing Every 6 Months GLP-1 Advanced tirzepatide Starting at (All Doses) Adds GIP receptor activation for broader insulin and satiety signalinghelpful when GLP-1 alone plateaus Ideal for patients needing extra glucose control or stronger appetite modulation for greater weight-loss goals 4 Weeks of Medication Ongoing Provider Care & Support Metabolic Lab Testing Every 6 Months Not actual vial For marketing purposes only GLP-1 Elite semaglutide + tirzepatide Starting at (All Doses) Dual GLP-1 + GIP with a combination of the Core and Advanced compounds designed to fully activate both GLP-1 and GIP receptors for maximal metabolic benefit Ideal for patients that have plateaued on other GLP-1 medication or needing the strongest appetite and glucose control 4 Weeks of Medication Ongoing Provider Care & Support Metabolic Lab Testing Every 6 Months GLP-1 Elite semaglutide + tirzepatide Starting at (All Doses) Dual GLP-1 + GIP with a combination of the Core and Advanced compounds designed to fully activate both GLP-1 and GIP receptors for maximal metabolic benefit Ideal for patients that have plateaued on other GLP-1 medication or needing the strongest appetite and glucose control 4 Weeks of Medication Ongoing Provider Care & Support Metabolic Lab Testing Every 6 Months Not actual vial For marketing purposes only NAD+ Therapy Starting at Maximum bioavailability through subcutaneous injections for rapid energy improvement Cellular energy reboot - raises NAD+ levels to power mitochondria and boost ATP production Pharmaceutical-Grade NAD+ Vials Ongoing Provider Care & Support NAD+ Therapy Starting at Maximum bioavailability through subcutaneous injections for rapid energy improvement Cellular energy reboot - raises NAD+ levels to power mitochondria and boost ATP production Pharmaceutical-Grade NAD+ Vials Ongoing Provider Care & Support Not actual vial For marketing purposes only Microdosing Tirzepatide lower-dose tirzepatide Starting at (1mg/week) Dual GLP-1 + GIP signaling at lower, capped doses designed to support long-term metabolic health and resiliencepromoting steady energy, cognitive clarity, and metabolic regulation while minimizing side effects Ideal for patients seeking sustainable, longevity-focused benefits over time (weight loss may occur, but isnt the primary aim) Medication shipped every 12 weeks Ongoing Provider Care & Support Microdosing Tirzepatide lower-dose tirzepatide Starting at (1mg/week) Dual GLP-1 + GIP signaling at lower, capped doses designed to support long-term metabolic health and resiliencepromoting steady energy, cognitive clarity, and metabolic regulation while minimizing side effects Ideal for patients seeking sustainable, longevity-focused benefits over time (weight loss may occur, but isnt the primary aim) Medication shipped every 12 weeks Ongoing Provider Care & Support GLP-1 Advanced tirzepatide GLP-1 Elite semaglutide + tirzepatide Microdosing Tirzepatide lower-dose tirzepatide *Prescription products require an online consultation with a healthcare professional who will determine if a prescription is appropriate
None of the study participants used any antidiabetic medications within the past six months of the study commencement and were considered new users. However, these patients received semaglutide prescriptions due to a history of hypertension, obesity, hypercholesterolemia, heart disease, or stroke
